Table 3.

Patient characteristics

Participant Code	Age range (years)	Time since diagnosis (years)	Treatment Type	Number of co-morbidities
Patient 1a	66–70	12	Surgery	0
Patient 2a	61–65	3	Surgery	2
Patient 3a, b	66–70	10	Surgery	1
Patient 4a	81–85	15	Radiotherapy	1
Patient 5a	81–85	5	Active Surveillance	1
Patient 6a	61–65	2	Surgery	0
Patient 7a	76–80	3	Radiotherapy & ADT	1
Patient 8a	76–80	5	ADT	1
Patient 9a	76–80	10	Surgery & ADT	0
Patient 10a	71–75	2	ADT	1
Patient 11b	76–80	13	Radiotherapy	1
Patient 12b	76–80	4	Radiotherapy & ADT	1
Patient 13b	76–80	5	Active Surveillance	0
Patient 14b	71–75	13	Surgery	0
Patient 15b	71–75	7	Radiotherapy & ADT	1
Patient 16b	81–85	2	ADT	2

Abbreviations: ADT Androgen Deprivation Therapy

^aDenotes patients interviewed in Phase 1

^bDenotes patients interviewed in Phase 2